Skip to main content

Advertisement

ADVERTISEMENT

Clinical Editor'S Corner

Clinical Editor's Corner
09/01/2024
We recently had a patient who presented us with a challenge to know whether the informed consent was valid, something I thought we’d address in this editor’s page. 
We recently had a patient who presented us with a challenge to know whether the informed consent was valid, something I thought we’d address in this editor’s page. 
We recently had a patient who...
09/01/2024
Cath Lab Digest
Clinical Editor's Corner
07/22/2024
For teaching centers, July 1st brings new faces to the cath lab, mostly in the form of cardiology trainees. Working with a brand-new cardiology fellow assigned to the cath lab prompted me to review how cath labs become great and how great...
For teaching centers, July 1st brings new faces to the cath lab, mostly in the form of cardiology trainees. Working with a brand-new cardiology fellow assigned to the cath lab prompted me to review how cath labs become great and how great...
For teaching centers, July 1st...
07/22/2024
Cath Lab Digest
Clinical Editor's Corner
07/02/2024
In a 2010 editor’s page, I summarized the opinions of several prominent interventionalists who expressed their interest and belief that the nil per os (NPO) order has outlived its usefulness. In our current environment, NPO does not have to...
In a 2010 editor’s page, I summarized the opinions of several prominent interventionalists who expressed their interest and belief that the nil per os (NPO) order has outlived its usefulness. In our current environment, NPO does not have to...
In a 2010 editor’s page, I...
07/02/2024
Cath Lab Digest

Advertisement

Clinical Editor's Corner
05/29/2024
Morton J. Kern, MD, MSCAI, FACC, FAHA
Every year, we graduate cardiology fellows and introduce them as new interventionalists into our community. It is our fervent hope and desire that they succeed and deliver great care to their patients.   
Every year, we graduate cardiology fellows and introduce them as new interventionalists into our community. It is our fervent hope and desire that they succeed and deliver great care to their patients.   
Every year, we graduate...
05/29/2024
Cath Lab Digest
Clinical Editor's Corner
04/30/2024

Morton Kern, with contributions from:
Dawn Abbott, Providence, Rhode Island;
James Blankenship, Albuquerque, New Mexico;
David Cohen, Roslyn, New York;
Kirk Garratt, Newark, Delaware; 
Steven L. Goldberg, Monterey, California;
Timothy D. Henry, Cincinnati, Ohio;
Neil Kleiman, Houston, Texas;
Lloyd Klein, Sonoma, California;
Ajay Kirtane, New York, New York; 
Mitchell Krucoff, Durham, North Carolina;
Michael Lim, Poplar Bluff, Missouri;
Jeffrey Moses, Roslyn, New York;
Duane Pinto, Boston, Massachusetts;
Steve Ramee, Baton Rouge, Louisiana;
Jennifer Tremmel, Palo Alto, California;
Fred Welt, Salt Lake City, Utah;
Bonnie Weiner, Worchester, Massachusetts;
Chris White, New Orleans, Louisiana

Morton Kern, with contributions from:...
I read an interesting article by Levi et al(1) that stimulated my curiosity on how our approach to the ST-elevation myocardial infarction (STEMI) patient has changed over the years. I asked my expert colleagues - Question 1: Do you believe...
I read an interesting article by Levi et al(1) that stimulated my curiosity on how our approach to the ST-elevation myocardial infarction (STEMI) patient has changed over the years. I asked my expert colleagues - Question 1: Do you believe...
I read an interesting article by...
04/30/2024
Cath Lab Digest
Clinical Editor's Corner
04/03/2024

Dr. Morton Kern with contributions from Drs. Richard Bach, Washington University, St. Louis, Missouri; David Cohen, St. Francis Hospital, Roslyn, New York; Douglas Drachman, Massachusetts General Hospital, Boston, Massachusetts; Kirk Garratt, ChristianaCare, Wilmington, Delaware; Ajay Kirtane, Columbia University, New York, New York; Steve Ramee, LSU Health Science Center, New Orleans, Louisiana; Barry Uretsky, University of Arkansas, Little Rock, Arkansas

Dr. Morton Kern with contributions fr...
After working to secure the pericardial drain in a patient after pericardiocentesis, Dr. Douglas Drachman shares an issue around the management of pericardial drains with Dr. Kern and his expert colleagues. They discuss what should be...
After working to secure the pericardial drain in a patient after pericardiocentesis, Dr. Douglas Drachman shares an issue around the management of pericardial drains with Dr. Kern and his expert colleagues. They discuss what should be...
After working to secure the...
04/03/2024
Cath Lab Digest

Advertisement

Clinical Editor's Corner
03/05/2024

Dr. Morton Kern with contributions from Drs. Steve Ramee, New Orleans, Louisiana; Jacqueline Saw, Vancouver, British Columbia; Jon Tobis, Los Angeles, California; Barry Uretsky, Little Rock, Arkansas.

Dr. Morton Kern with contributions fr...
Although some of the causes of myocardial infarction with no coronary artery obstruction (MINOCA) are often unknown, spontaneous coronary artery dissection (SCAD) in MINOCA should always be considered early on as one of the major etiologies...
Although some of the causes of myocardial infarction with no coronary artery obstruction (MINOCA) are often unknown, spontaneous coronary artery dissection (SCAD) in MINOCA should always be considered early on as one of the major etiologies...
Although some of the causes of...
03/05/2024
Cath Lab Digest
Clinical Editor's Corner
02/04/2024

Dr. Morton J. Kern with contributions from Drs.:

  • David J. Cohen, St. Francis Hospital, Roslyn, New York;
  • Kirk Garratt, Christiana Medical Center, Newark, Delaware;
  • Spencer King, Atlanta, Georgia;
  • Neal S. Kleiman, Methodist DeBakey Heart and Vascular Center, Houston, Texas;
  • Srihari S. Naidu, Westchester Medical Center, Valhalla, New York;
  • Matthew J. Price, Scripps Clinic, La Jolla, California;
  • Steve Ramee, Ochsner Clinic, New Orleans, Louisiana;
  • Chet Rihal, Mayo Clinic, Rochester, Minnesota;
  • Bonnie Weiner, Worcester, Massachusetts.
Dr. Morton J. Kern with contributions...
While the SGLT2 inhibitors and GLP-1 agonists were new to me in terms of their potential impact on our procedures, we will likely hold these medications before elective invasive and interventional cardiac procedures.
While the SGLT2 inhibitors and GLP-1 agonists were new to me in terms of their potential impact on our procedures, we will likely hold these medications before elective invasive and interventional cardiac procedures.
While the SGLT2 inhibitors and...
02/04/2024
Cath Lab Digest
Clinical Editor's Corner
01/04/2024

Drs. Morton J. Kern and Arnold H. Seto with Drs. James Blankenship, Albuquerque, New Mexico; William Fearon, Palo Alto, California; Matheen A. Khuddus, Gainesville, Florida; Bonnie Weiner, Worchester, Massachusetts

Drs. Morton J. Kern and Arnold H. Set...
Dr. Kern and his expert colleagues discuss a specific angiographic question: “Should final angiography always be done with the guide wire in or out of the artery?”
Dr. Kern and his expert colleagues discuss a specific angiographic question: “Should final angiography always be done with the guide wire in or out of the artery?”
Dr. Kern and his expert...
01/04/2024
Cath Lab Digest

Advertisement

Clinical Editor's Corner
12/04/2023

Morton J. Kern, MD, and Arnold Seto, MD, MPA, Long Beach, California, with contributions from J. Dawn Abbott, MD, Providence, Rhode Island; Douglas E. Drachman, MD, Boston, Massachusetts; Dmitriy N. Feldman, MD, New York, New York

Morton J. Kern, MD, and Arnold Seto, ...
"I had a 6 French [F] radial sheath in situ, and wanted to perform a 7F intervention, but didn’t want to convert to femoral. What methods have you used to upsize radial sheaths?”
"I had a 6 French [F] radial sheath in situ, and wanted to perform a 7F intervention, but didn’t want to convert to femoral. What methods have you used to upsize radial sheaths?”
"I had a 6 French [F] radial...
12/04/2023
Cath Lab Digest

Advertisement